article

Expert view: Enabling Pharma 4.0 through digital transformation

Posted: 26 October 2020 | | No comments yet

Digital transformation refers to the advent of various new and advancing technologies and their application in business to drive organisational efficiencies that would otherwise be impossible to achieve.

As the world leader in serving science, Thermo Fisher Scientific Inc. (NYSE: TMO) is partnering with customers to connect the physical and the digital. Our state-ofthe-art laboratory data management solutions help our pharmaceutical and biopharmaceutical customers to accelerate their digital transformation by orchestrating their laboratory operations while addressing regulatory and business challenges.

The Thermo Scientific SampleManager LIMS software suite is a complete solution that includes LIMS (laboratory information management system), LES (lab execution system), ELN (electronic lab notebook) and SDMS (scientific data management system). Half of the world’s top 10 pharmaceutical companies as well as Thermo Fisher Scientific’s pharma services business rely on SampleManager LIMS software to streamline operations ensuring consistency, efficiency and productivity across their manufacturing QA/QC laboratories.

Connecting quality data from the manufacturing plant and the laboratory gives organisations a holistic view enabling them to execute on their Pharma 4.0 strategy. Through integrated, end-to-end workflows, organisations are able to monitor data in real time and adopt a truly agile manufacturing process which self-adjusts to ensure the quality of their drug product.

Organisations need to adopt the technology, people and process changes needed to align their business to the Pharma 4.0 model. Achieving a smart factory requires a smart laboratory and connected information systems. Digital transformation is the key to achieving Pharma 4.0 and Thermo Fisher Scientific is uniquely positioned to support pharmaceutical organisations through this journey.